Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old
Clinical trial NCT01730378 · COMPLETED
Trial details
- NCT number
- NCT01730378
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-05
- Primary completion
- 2013-12-17
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.